Overview of phase I studies of intravenous administration of PV701, an oncolytic virus

Recombinant Newcastle disease virus as a vaccine vector

TNF-related apoptosis-inducing ligand mediates tumoricidal activity of human monocytes stimulated by Newcastle disease virus

Postirradiation malignant fibrous histiocytoma of the larynx: a case report

Human tumor cell infection by Newcastle Disease Virus leads to upregulation of HLA and cell adhesion molecules and to induction of interferons, chemokines and finally apoptosis

Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers

Heat shock and heat shock protein 70i enhance the oncolytic effect of replicative adenovirus

Newcastle disease virus therapy of human tumor xenografts: antitumor effects of local or systemic administration

Antitumor effects of Newcastle Disease Virus in vivo: local versus systemic effects

Preliminary results of active specific immunization with modified tumor cell vaccine in glioblastoma multiforme